Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population

Thrombosis Research

Volumn 132, Issue 5, 2013, Pages 520-526

  Mahan, Charles E ^a   Fisher, Maxine D ^b   Mills, Roger M ^c   Fields, Larry E ^c   Stephenson, Judith J ^b   Fu, An Chen ^b   Spyropoulos, Alex C ^d  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b HEALTHCORE INC   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^d DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

Medical patients; Mortality; Risk factors; Thromboprophylaxis; Venous thromboembolism

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; COHORT ANALYSIS; DRUG UTILIZATION; FEMALE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; THROMBOPHILIA; TREATMENT OUTCOME; VARICOSIS; VENOUS THROMBOEMBOLISM;

CI; CONFIDENCE INTERVAL; DCI; DEEP VEIN THROMBOSIS; DEYO-CHARLSON COMORBIDITY INDEX; DVT; HAZARD RATIO; HEALTHCORE INTEGRATED RESEARCH DATABASE; HIRD; HR; ICD-9-CM; INTERNATIONAL CLASSIFICATION OF DISEASES, NINTH REVISION, CLINICAL MODIFICATION; LMWH; LOW-MOLECULAR-WEIGHT HEPARIN; MEDICAL PATIENTS; MORTALITY; ODDS RATIO; OR; PE; PULMONARY EMBOLISM; RISK FACTORS; SD; STANDARD DEVIATION; THROMBOPROPHYLAXIS; VENOUS THROMBOEMBOLISM; VTE;

AGED; ANTICOAGULANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PATIENT DISCHARGE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84886097093     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.08.013     Document Type: Article

References (37)

1. P. Prandoni, A.W.A. Lensing, A. Cogo, S. Cuppini, S. Villalta, and M. Carta The long-term clinical course of acute deep vein thrombosis Ann Intern Med 125 1996 1 7
2. C. Zhan, and M.R. Miller Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization JAMA 290 2003 1868 1874
3. C. Kearon Natural history of venous thromboembolism Circulation 107 2003 I22 130
4. G. Piazza, and S.Z. Goldhaber Physician alerts to prevent venous thromboembolism J Thromb Thrombolysis 30 2010 1 6
5. J.A. Heit, A.T. Cohen, F.A. Anderson on behalf of the VTA Impact Assessment Group Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US [ASH abstract 910] Blood 106 2005 93
6. F.A. Spencer, D. Lessard, C. Emery, G. Reed, and R.J. Goldberg Venous thromboembolism in the outpatient setting Arch Intern Med 167 2007 1471
7. J.A. Heit, M. O'Fallon, T.M. Petterson, C.M. Lohse, M.D. Silverstein, and D.N. Mohr Relative impact of risk factors for deep vein thrombosis and pulmonary embolism. A population-based study Arch Intern Med 162 2002 1245 1248
8. F.A. Anderson, M. Zayaruzny, J.A. Heit, D. Fidan, and A.T. Cohen Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism Am J Hematol 82 2007 777 782
9. S.C. McKean, S.B. Deitelzweig, A. Sasahara, F. Michota, and A. Jacobson Assessing the risk of venous thromboembolism and identifying barriers to thromboprophylaxis in the hospitalized patient J Hosp Med 4 2009 S1 S7
10. L.G. Futterman, and L. Lemberg A silent killer - often preventable Am J Crit Care 13 2004 431 436
11. G. Piazza, J. Fanikos, M. Zayaruzny, and S.Z. Goldhaber Venous thromboembolic events in hospitalized medical patients Thromb Haemost 102 2009 505 510
12. T.P. Baglin, K. White, and A. Charles Fatal pulmonary embolism in hospitalized medical patients J Clin Pathol 50 1997 609 610
13. A.T. Cohen, V.F. Tapson, J.-F. Bergmann, S.Z. Goldhaber, A.K. Kakkar, and B. Deslandes Venous thromboembolism risk and prophylaxis in the acute hospital setting (ENDORSE study): a multinational cross-sectional study Lancet 371 2008 387 394
14. G.J. Stashenko, and V.F. Tapson Prevention of venous thromboembolism in medical patients and outpatients Nat Rev Cardiol 6 2009 356 363
15. A.C. Spyropoulos, M. Hussein, J. Lin, and D. Battleman Rates of venous thromboembolism occurrence in medical patients among the insured population Thromb Haemost 102 2009 951 957
16. J. Edelsberg, M. Hagiwara, C. Taneja, and G. Oster Risk of venous thromboembolism among hospitalized medically ill patients Am J Health Syst Pharm 63 20 Suppl. 6 2006 S16 S22
17. A. Leizorovicz, A.T. Cohen, A.G.G. Turpie, C.G. Olsson, P.T. Vaitkus, and S.Z. Goldhaber Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients Circulation 110 2004 874 879
18. M.M. Samama, A. Thomas, J.-Y. Darmon, L. Desjardins, A. Eldor, and C. Janbon A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients N Engl J Med 341 1999 793 800
19. V.F. Tapson, H. Decousus, M. Pini, B.H. Chong, J.B. Froehlich, and M. Monreal Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients Chest 132 2007 936 945
20. A. Amin, A.C. Spyropoulos, P. Dobesh, A. Shorr, M. Hussein, and E. Mozaffari Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE START) J Thromb Thrombolysis 29 2010 326 339
21. H.T. Yu, M.L. Dylan, J. Lin, and R.W. Dubois Hospitals' compliance with prophylaxis guidelines for venous thromboembolism Am J Health Syst Pharm 64 2007 69 76
22. A.N. Amin, J. Lin, S. Thompson, and D. Wiederkehr Real-World Rates of In-hospital and Post discharge Deep-Vein Thrombosis and Pulmonary Embolism in At-Risk Medical Patients in the United States Clin Appl Thromb Hemost 17 2011 611 619
23. A.N. Amin, S. Stemkowski, J. Lin, and G. Yang Inpatient thromboprophylaxis use in U.S. hospitals: adherence to the seventh American College of Chest Physician's recommendations for at-risk medical and surgical patients J Hosp Med 4 2009 E15 E21
24. A. Amin, S. Stemkowski, J. Lin, and G. Yang Thromboprophylaxis rates in US medical centers: success or failure? J Thromb Haemost 5 2007 1610 1616
25. S.R. Kahn, W. Lim, A.S. Dunn, M. Cushman, F. Dentali, and E.A. Akl Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 141 2 Suppl. 2012 e195S e226S
26. F.A. Lederle, D. Zylla, R. MacDonald, and T.J. Wilt Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline Ann Intern Med 155 2011 602 615
27. R.D. Hull, S.M. Schellong, V.F. Tapson, M. Monreal, M.M. Samama, and P. Nicol EXCLAIM (Extended Prophylaxis for Venous ThromboEmbolism in Acutely Ill Medical Patients With Prolonged Immobilization) study. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial Ann Intern Med 153 2010 8 18
28. P.M. Wahl, K. Rodgers, S. Schneeweiss, B.F. Gage, J. Butler, and C. Wilmer Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population Pharmacoepidemiol Drug Saf 19 2010 596 603
29. L. Tamariz, T. Harkins, and V. Nair A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data Pharmacoepidemiol Drug Saf 21 Suppl. 1 2012 154 162
30. C.E. Mahan, A.C. Spyropoulos, M.D. Fisher, L.E. Fields, R.M. Mills, and J.J. Stephenson Antithrombotic medication use and bleeding risk in medically ill patients after hospitalization Clin Appl Thromb Hemost 19 5 2013 Sep 504 512
31. N. Kucher, V.F. Tapson, and S.Z. Goldhaber DVT FREE Steering Committee. Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients Thromb Haemost 93 2005 494 498
32. A.C. Spyropoulos, F.A. Anderson Jr., G. Fitzgerald, H. Decousus, M. Pini, and B.H. Chong Predictive and associative models to identify hospitalized medical patients at risk for venous thromboembolism Chest 140 2011 706 714
33. S. Snowden, and L. Silus Oral anticoagulation with warfarin for patients with left ventricular systolic dysfunction Cardiol Rev 19 2011 36 40
34. S.Z. Goldhaber, A. Leizorovicz, A.K. Kakkar, S.K. Haas, G. Merli, and R.M. Knabb Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients N Engl J Med 365 2011 2167 2177
35. A.T. Cohen, T.E. Spiro, H.R. Büller, L. Haskell, D. Hu, R. Hull, A. Mebazaa, G. Merli, S. Schellong, and A.C. Spyropoulos Tapson V; MAGELLAN Investigators. Rivaroxaban for thromboprophylaxis in acutely ill medical patients N Engl J Med. 368 6 2013 513 523
36. A.T. Cohen, T.E. Spiro, H.R. Buller, A. Mebazaa, S. Schellong, G. Merli, V.F. Tapson, R. Hull, D. Hu, and Haskell Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients (MAGELLAN subgroup analyses) J Thromb Haemost 9 S2 2011 21
37. J. Stausberg, D. Koch, J. Ingenerf, and M. Betzler Comparing Paper-based with Electronic Patient Records: Lessons Learned during a Study on Diagnosis and Procedure Codes J Am Med Inform Assoc 10 2003 470 477